15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
On January 13, 2020, the U.S. Department of Labor (DOL) released its highly anticipated Final Rule r...
Read More >
This week’s guest on the Innovation In Compliance show is Sean Freidlin, Director of Product Market...
Read More >
Red faces – no gross misconduct when employee revealed executive's pay - The EAT had to consider w...
Read More >
Against a global backdrop that saw M&A slip 9% by both value and volume year on year, the financial ...
Read More >
Generally, a 403(b) plan is a retirement planning program whereby a public school or tax-exempt 501(...
Read More >
On Monday, August 17, 2020, Baker Donelson's Clinton Sanko sat down with Wendell Jisa, CEO of Reveal...
Read More >